Do you know Predilife, the company specializing in predictive and personalized medicine? We tell you all about this innovative, fast-growing solution, which has been listed on Euronext Growth since 2018! 

Predilife in a nutshell

Founded in 2004, Predilife is a pioneer in the design and development of predictive tests for the prevention of major diseases - "predict to prevent"is its slogan. The company's work is based on artificial intelligence methods combined with clinical and genetic medical data. A method that enables earlier identification of pathologies. As a result, individuals can adapt their lifestyles and benefit frommore targeted medical follow-up.

And the figures keep rising!

The methods used by Predilife are seductive. Indeed, this French healthcare nugget has been growing rapidly in recent years. The company's sales are expected to reach 52,000 euros in 2020, 142,000 euros in 2021 and 289,000 euros in 2022. Sales are doubling or even tripling every year. The company has no intention of stopping there. As Predilife CEO Stéphane Ragusa said at the 2022 annual results: " Our business continues to grow, with sales doubling every year since 2019. Our corporate offering is meeting with a very positive response from employees, with excellent recommendation rates that allow us to anticipate the sustainable continuation of this growth rate. "

His future projects

Today, Predilife is particularly attractive to public-sector companies/institutions, with partners such as the American Hospital of Paris, Institut Français du Sein and Hôpitaux du Léman. However, the company also counts private-sector players such as the Lactalis group , Marionnaud and TF1 among its customers . It is this range of customers that Predilife would like to expand in the future.

Predilife: key information

We're talking about them! 

BFM TV.com: PREDILIFE: "SOLUTIONS FOR PREVENTION RATHER THAN CURE".

Le Figaro.fr : PREDILIFE: the specialist in predictive medicine

-

David B - Financial expert